Annual Long Term Debt
$0.00
-$4.00 M-100.00%
December 31, 2023
Summary
- As of February 26, 2025, SYRE annual long term debt is $0.00, with the most recent change of -$4.00 million (-100.00%) on December 31, 2023.
- During the last 3 years, SYRE annual long term debt has fallen by -$5.13 million (-100.00%).
- SYRE annual long term debt is now -100.00% below its all-time high of $5.13 million, reached on December 1, 2020.
Performance
SYRE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
N/A
September 30, 2024
Summary
- SYRE quarterly long term debt is not available.
Performance
SYRE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
SYRE Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | -100.0% | - |
| 5 y5 years | 0.0% | - |
SYRE Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||
| 5 y | 5-year | -100.0% | at low | ||
| alltime | all time | -100.0% | at low |
Spyre Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $3.82 M(-4.5%) |
| Dec 2022 | $4.00 M(-13.4%) | - |
| Dec 2022 | - | $4.00 M(-3.7%) |
| Sep 2022 | - | $4.16 M(-3.6%) |
| Jun 2022 | - | $4.32 M(-3.4%) |
| Mar 2022 | - | $4.47 M(-3.4%) |
| Dec 2021 | $4.62 M | $4.62 M(-2.6%) |
| Sep 2021 | - | $4.75 M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $4.88 M(-2.6%) |
| Mar 2021 | - | $5.01 M(-2.3%) |
| Dec 2020 | $5.13 M(+8.8%) | $5.13 M(+3.7%) |
| Sep 2020 | - | $4.95 M(+5.4%) |
| Jun 2020 | - | $4.70 M(-2.5%) |
| Mar 2020 | - | $4.82 M(+2.2%) |
| Dec 2019 | $4.71 M(>+9900.0%) | $4.71 M(-3.2%) |
| Sep 2019 | - | $4.87 M(+1.1%) |
| Jun 2019 | - | $4.82 M(+1194.4%) |
| Mar 2019 | - | $372.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Spyre Therapeutics annual long term debt?
- What is the all time high annual long term debt for Spyre Therapeutics?
- What is Spyre Therapeutics annual long term debt year-on-year change?
- What is the all time high quarterly long term debt for Spyre Therapeutics?
What is Spyre Therapeutics annual long term debt?
The current annual long term debt of SYRE is $0.00
What is the all time high annual long term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high annual long term debt is $5.13 M
What is Spyre Therapeutics annual long term debt year-on-year change?
Over the past year, SYRE annual long term debt has changed by -$4.00 M (-100.00%)
What is the all time high quarterly long term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly long term debt is $5.13 M